• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español

You are here

Yttrium-90 and Rhenium-188 Radiopharmaceuticals for Radionuclide Therapy

English STI/PUB/1662 978-92-0-103814-2
301 164 52.00 2015

Download PDF (10.09 MB)

Description

A key requirement for the effective implementation of the therapeutic approach, based on the intravenous administration of radiolabelled compounds (radionuclide therapy), is the sufficient availability of radionuclides with appropriate physical characteristics. Based on their nuclear properties, 188Re and 90Y are considered among the most interesting radionuclides for therapy. Furthermore, they are produced through portable generators, which give opportunities for ensuring a worldwide distribution of these radionuclides. This publication illustrates recent studies aimed at investigating efficient quality control methods to ensure both the radionuclidic purity of generator eluates, and the proper preparation of new target specific 188Re and 90Y radiopharmaceuticals for various clinical applications.

More Information on reusing IAEA copyright material.

Keywords

IAEA Radioisotopes and Radiopharmaceuticals, Nuclear Medicine, Radionuclide Therapy, Radionuclide Generators, Yttrium 90, Rhenium 188, Isotopes, Therapeutic Use, Impurities, Quality Control, Nuclear Properties, Clinical

How to order

Ordering Locally

Please use the following links for an up-to-date list of IAEA distributors:

Distributors of IAEA Publications


Orders and requests for information may also be addressed to:

Marketing and Sales Unit
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria

Tel.: +43 1 2600 22529, +43 1 2600 22530
Fax: +43 1 2600 29302
Email: sales.publications@iaea.org


Download order form

Resources

  1. Employment
  2. Women
  3. Press

Stay in touch

Newsletter